SK Capital Partners Acquires Majority Stake in Lacerta Group
January 11, 2021
Funds advised by SK Capital Partners have acquired a majority interest in Lacerta Group, a Mansfield, Massachusetts-based manufacturer of thermoformed PET packaging solutions. The investment will support Lacerta's continued growth and scaling of its in-house manufacturing capabilities while founders Ali and Mory Lotfi retain a significant ownership stake.
- Buyers
- SK Capital Partners (funds advised by SK Capital)
- Targets
- Lacerta Group, Inc.
- Sellers
- Ali Lotfi, Mory Lotfi
- Industry
- Packaging
- Location
- Massachusetts, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Lacerta Group Acquires Substantially All Assets of Portage Plastics
December 21, 2022
Manufacturing
Lacerta Group acquired substantially all the assets of Portage Plastics Corporation and PPC Investments, LLC (together, Portage Plastics) on December 21, 2022, expanding its production footprint into Portage, Wisconsin. The deal included retention of more than 50 Portage Plastics employees and will support Lacerta's efforts to better serve customers in the Midwest and Central United States; Lacerta is a portfolio company of SK Capital Partners.
-
SK Capital Partners Acquires IPACKCHEM Group SAS
April 6, 2021
Manufacturing
SK Capital Partners, a New York-based private investment firm focused on specialty materials and chemicals, has completed the acquisition of IPACKCHEM Group SAS, a Paris-headquartered manufacturer of sustainability-oriented barrier plastic packaging for the crop protection and specialty chemicals markets. SK Capital said it will partner with IPACKCHEM's management to accelerate organic and acquisitive growth and expand the company's global market position.
-
Great Point Partners Recapitalizes SteriPack
June 17, 2019
Medical Devices
Great Point Partners completed a growth recapitalization of SteriPack to support the contract manufacturer's next phase of expansion and an aggressive add-on acquisition strategy. SteriPack, headquartered in Mullingar, Ireland, is a contract manufacturer and value‑added services provider to medical device and pharmaceutical customers with ~650 employees and facilities in Poland, Malaysia and the United States.
-
Arsenal Capital Partners Invests $449M in Certara
December 8, 2022
Biotechnology
Arsenal Capital Partners closed a previously announced $449 million stock purchase in Certara, acquiring shares from funds controlled by EQT Private Equity and becoming a long-term minority investor. As part of the transaction Arsenal appointed Operating Partner David Spaight to Certara's board while Stephen McLean remains a director; Arsenal agreed to a two-year lock-up on the newly purchased shares.
-
Ampersand Capital Partners Acquires CurTec
July 21, 2025
Packaging
Ampersand Capital Partners has acquired CurTec Group B.V., a Netherlands-based manufacturer of high-performance plastic packaging for pharmaceutical and specialty chemical applications, from Bencis Capital Partners in partnership with CurTec management. The deal positions Ampersand to scale CurTec's U.S. footprint, accelerate product innovation, and expand capacity and commercial capabilities to serve pharma and specialty chemicals customers globally.
-
Clearlake Capital Acquires Pretium Packaging from Genstar Capital
January 15, 2020
Packaging
Clearlake Capital Group, in partnership with Pretium management, has acquired Pretium Packaging from Genstar Capital. Pretium is a leading North American designer and manufacturer of rigid plastic packaging (containers, bottles, closures) headquartered in Chesterfield, Missouri, with a national footprint of 19 facilities; financial terms were not disclosed. Clearlake intends to operate Pretium as a buy-and-build platform to drive organic growth and pursue add-on acquisitions.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.